Tag: FDA Warning Letter

LITIGATION ROUND-UP

Settlements Sanofi-Aventis reached a settlement in August 2013 with the Maryland Attorney General and other states for alleged violations of federal and state anti-kickback statutes related to its osteoarthritis drug Hyalgan.  The government alleged that Sanofi provided free Hyalgan units with knowledge that doctors could receive Medicaid reimbursement and/or were expected to buy additional quantities […]

FDA Warning Letter Over Facebook, Testimonials, Metatags

The Food and Drug Administration (FDA) recently released a warning letter to Vibrant Life, stating that claims made on Vibrant Life’s Facebook page and its other websites violate the Federal Food, Drug, and Cosmetic Act (FDCA).  In its warning letter, the FDA cites a number of improper claims made by the […]

FDA Continues Enforcement Against Internet Marketing of Unapproved and Misbranded Drugs

EvaPharmacy recently received a Warning Letter from the United States Food and Drug Administration (“FDA”), Office of Drug Security, Integrity and Recalls regarding products available for sale to consumers in the United States on its websites.  The FDA requested that EvaPharmacy take prompt action and notify the FDA within ten […]